PATENT CLAIM ANALYSIS

Application Number: 16139351
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["514", "526000"]

Abstract:
The present invention relates to purified 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt thereof, and a method for preparing such compound. The compound has at least 90% (w/w) purity. The present invention is also directed to a pharmaceutical composition comprises the purified compound and a pharmaceutically acceptable carrier. The present invention is further directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.

Claim (Index 6):
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of 3-methanesulfonylpropionitrile or a pharmaceutically acceptable solvate thereof, wherein the composition is in a topical form of gels, creams, lotions, or patches.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.82
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13324777', '14216664', '15712269', '13759676', '15349161']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.746327922548574
- 35 USC 102 Novelty (BERT): 0.5120975031249275
- Combined Prediction Score: 0.7229048806062094
- Mean Citation Score: 295.16879400000005
- Max Citation Score: 306.4056700000001
- Similarity Product: 282.88752497213727

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test